Statement: There are no cases of Vertigo in the primary trial or the primary trial.
Primary_evidence: Adverse Events 1:   Total: 4/104 (3.85%)   Neutropenia 1/104 (0.96%)   Leukopenia 2/104 (1.92%)   paranasal sinus reaction 1/104 (0.96%)   cellulitis 1/104 (0.96%) Adverse Events 2:
Secondary_evidence: Adverse Events 1:   Total: 1/4 (25.00%)   Vertigo 0/4 (0.00%)   Abdominal adhesions 0/4 (0.00%)   Abdominal distension 0/4 (0.00%)   Abdominal pain 0/4 (0.00%)   Diarrhoea 0/4 (0.00%)   Nausea 0/4 (0.00%)   Vomiting 0/4 (0.00%)   Disease progression 0/4 (0.00%)   Influenza 0/4 (0.00%)   Nasopharyngitis 0/4 (0.00%)   Lumbar vertebral fracture 0/4 (0.00%)   Hyponatraemia 0/4 (0.00%)   Ataxia 0/4 (0.00%)